| Literature DB >> 25723390 |
Gang Liu1, Guan Yang2, Guiping Guan2, Yuzhe Zhang1, Wenkai Ren3, Jie Yin3, Yordan Martínez Aguilar1, Wei Luo4, Jun Fang2, Xinglong Yu4, Tiejun Li1, Yulong Yin1.
Abstract
The present study was performed to determine the protective role of dietary selenium (Se) yeast supplementation in porcine circovirus type 2 (PCV2) infected mice. Forty-eight Kun Ming female mice were randomly assigned to Se yeast group (0.3%Se +basal diet, n = 24) and control group (basal diet, n = 24). After 3 days of adaptive feeding and 15 days treatment with the experimental feed, mice were challenged by intraperitioneal injection of PCV2 at the dosage of 2000 TCID50 (50% tissue culture infection dose, TCID50). Serum total superoxide dismutase (SOD) activity, malondialdehyde (MDA) level, tumor necrosis factor alpha (TNF-α), C-reactive protein (CRP) and interleukin-1 beta (IL-1β) levels were measured at 5, 10, 15, 20 days post infection (dpi). The PCV2 virus load in the liver, spleen and lung, and the microscopic lesions in the liver, spleen and lung also were determined on 5, 10, 15, and 20 dpi. Dietary Se yeast supplementation decreased (Pμ0.05) the serum levels of TNF-α, but had no significant effect on the activity of SOD and the levels of MDA, CRP and IL-1β between experimental and control groups. Dietary Se yeast supplementation had little effect on the PCV2 virus load in the liver, spleen and lung. However, mice in the selenium yeast group showed a significant decrease in microscopic lesion scores in the lung and spleen compared with those in the control group (Pμ0.05). These data indicate Se yeast attenuated the PCV2 infection through altering the systemic inflammation and maintaining the normal organ morphology.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25723390 PMCID: PMC4344303 DOI: 10.1371/journal.pone.0115833
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Effects of dietary selenium yeast supplementation on serum superoxide dismutase (SOD) activity and malondialdehyde (MDA) level.
| Items | 5dpi | 10dpi | 15dpi | 20dpi |
|---|---|---|---|---|
| SOD(U/ml) | ||||
| Selenium group | 213.29±9.63 | 205.92±8.19 | 226.72±10.86 | 205.40±6.23 |
| Control group | 211.52±8.65 | 196.29±11.63 | 222.44±8.79 | 209.36±15.29 |
| MDA(nmol/ml) | ||||
| Selenium group | 13.10±3.15 | 13.72±3.86 | 13.86±3.66 | 16.71±6.78 |
| Control group | 15.43±3.16 | 14.82±4.11 | 10.54±1.56 | 19.15±2.65 |
Data are mean ± SEM, n = 6. SOD: superoxide dismutase, MDA: Malondialdehyde, Mice in Selenium yeast group are fed with 0.3%Se yeast +basal diet; while mice in control group are fed with basal diet.
Effects of dietary selenium yeast supplementation on serum levels of C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β).
| Items | 5dpi | 10dpi | 15dpi | 20dpi |
|---|---|---|---|---|
| CRP(μg/ml) | ||||
| Selenium group | 92.10±14.32 | 73.09±4.85 | 83.22±7.02 | 77.81±9.33 |
| Control group | 76.89±3.74 | 90.27±8.73 | 88.71±2.18 | 63.10±19.23 |
| TNF-α(pg/ml) | ||||
| Selenium group | 43.00±1.66 | 81.83±19.54 | 82.38±18.79 | 65.73±28.98 |
| Control group | 130.14±18.76 | 420.02±97.67 | 168.03±28.23 | 374.45±65.67 |
| IL-1β(ng/ml) | ||||
| Selenium group | 35.16±1.77 | 29.11±1.99 | 33.80±2.21 | 28.37±2.32 |
| Control group | 32.24±1.65 | 29.96±2.51 | 29.47±2.87 | 27.78±2.10 |
Data are mean ± SEM, n = 6. Selenium group means 0.3%selenium yeast +basal diet, control group means basal diet. CRP: C-reactive protein, TNF-α: Tumor necrosis factor alpha, IL-1β: Interleukin-1 beta.
**Mean values sharing different superscripts within a column differ (P< 0.01).
* Mean values sharing different superscripts within a column differ (P< 0.05).
PCV2 virus load in the liver, spleen and lung in selenium yeast group and control group.
| Items | 5dpi | 10dpi | 15dpi | 20dpi |
|---|---|---|---|---|
| Liver | ||||
| Selenium group | 8/10(3.9±0.2) | 0/10(0.0±0.0) | 10/10(4.5±0.3) | 7/10(4.1±0.3) |
| Control group | 8/10(6.4±1.3) | 0/10(0.0±0.0) | 8/10(5.5±1.0) | 0/10(0.0±0.0) |
| Spleen | ||||
| Selenium group | 5/10(5.7±1.0) | 0/10(0.0±0.0) | 4/10(11.3±1.5) | 4/10(8.9±2.0) |
| Control group | 0/10(0.0±0.0) | 0/10(0.0±0.0) | 4/10(12.6±0.8) | 0/10(0.0±0.0) |
| Lung | ||||
| Selenium group | 10/10(4.3±0.1) | 8/10(4.3±0.2) | 5/10(4.7±0.9) | 0/10(0.0±0.0) |
| Control group | 8/10(9.2±1.6) | 0/10(0.0±0.0) | 5/10(5.0±0.6) | 8/10(7.1±1.4) |
No. positive mice /No. tested mice, PCV2: porcine circovirus type 2, the data are shown as the mean PCV2 log10 genomic copies per gram samples ±standard error of the mean (SEM). Mice in Selenium yeast group are fed with 0.3%Se yeast +basal diet; while mice in control group are fed with basal diet.
**Mean values sharing different superscripts within a column differ (P< 0.01).
Fig 1Histopathological findings in the lung and spleen(×100).
The selenium yeast group shows less-severe lymphoid depletion (A) in the spleen compared with the control group (B). Additionally, mild interstitial pneumonia is evident in the lung in the selenium yeast group (C) compared with the control group (D). Mice in Selenium yeast group are fed with 0.3%Se yeast +basal diet; while mice in control group are fed with basal diet.
Microscopic lesion scores for tissue samples in PCV2-infected mice.
| Items | 5dpi | 10dpi | 15dpi | 20dpi |
|---|---|---|---|---|
| Lung | ||||
| Selenium group | 0 | 0 | 0 | 1.00±0.57 |
| Control group | 0 | 1.33±0.32 | 0.67±0.34 | 2.34±0.87 |
| Spleen | ||||
| Selenium group | 1.25±0.25 | 0.75±0.25 | 1.40±0.24 | 0.60±0.24 |
| Control group | 1.80±0.37 | 1.00±0.40 | 1.50±0.27 | 1.40±0.50 |
| Liver | ||||
| Selenium group | 0 | 0 | 0 | 0 |
| Control group | 0 | 0 | 0 | 0 |
PCV2: porcine circovirus type 2. Mice in Selenium yeast group are fed with 0.3%Se yeast +basal diet; while mice in control group are fed with basal diet.
**Mean values sharing different superscripts within a column differ (P< 0.01).
* Mean values sharing different superscripts within a column differ (P< 0.05).